{"The": [0], "increasing": [1], "number": [2], "of": [3, 86, 130, 146, 166, 179, 197, 204], "approved": [4, 198], "nucleic": [5, 40, 87, 153, 180], "acid": [6, 41, 88, 154, 181], "therapeutics": [7, 42], "demonstrates": [8], "the": [9, 83, 108, 114, 144, 175], "potential": [10], "to": [11, 191], "treat": [12], "diseases": [13], "by": [14], "targeting": [15], "their": [16, 184], "genetic": [17, 134, 148, 199], "blueprints": [18], "in": [19, 174], "vivo.": [20], "Conventional": [21], "treatments": [22], "generally": [23], "induce": [24], "therapeutic": [25], "effects": [26, 49], "that": [27, 65, 80, 122, 170, 189, 201], "are": [28, 171], "transient": [29], "because": [30], "they": [31], "target": [32, 72], "proteins": [33], "rather": [34], "than": [35], "underlying": [36], "causes.": [37], "In": [38, 136], "contrast,": [39], "can": [43], "achieve": [44], "long-lasting": [45], "or": [46, 55], "even": [47], "curative": [48], "via": [50], "gene": [51], "inhibition,": [52], "addition,": [53, 137], "replacement": [54], "editing.": [56], "Their": [57], "clinical": [58, 84, 111, 124, 192], "translation,": [59], "however,": [60], "depends": [61], "on": [62], "delivery": [63, 178], "technologies": [64, 79, 142, 169], "improve": [66], "stability,": [67], "facilitate": [68], "internalization": [69], "and": [70, 99, 126, 158, 194], "increase": [71], "affinity.": [73], "Here,": [74], "we": [75, 106, 138], "review": [76], "four": [77, 167], "platform": [78, 168], "have": [81], "enabled": [82], "translation": [85, 125], "therapeutics:": [89], "antisense": [90], "oligonucleotides,": [91], "ligand-modified": [92], "small": [93], "interfering": [94], "RNA": [95, 157], "conjugates,": [96], "lipid": [97], "nanoparticles": [98], "adeno-associated": [100], "virus": [101], "vectors.": [102], "For": [103], "each": [104], "platform,": [105], "discuss": [107, 139], "current": [109], "state-of-the-art": [110], "approaches,": [112], "explain": [113], "rationale": [115], "behind": [116], "its": [117], "development,": [118], "highlight": [119], "technological": [120], "aspects": [121], "facilitated": [123], "provide": [127], "an": [128, 164], "example": [129], "a": [131], "clinically": [132], "relevant": [133], "drug.": [135], "how": [140], "these": [141, 205], "enable": [143], "development": [145], "cutting-edge": [147], "drugs,": [149], "such": [150], "as": [151], "tissue-specific": [152], "bioconjugates,": [155], "messenger": [156], "gene-editing": [159], "therapeutics.": [160], "This": [161], "Review": [162], "provides": [163], "overview": [165], "currently": [172], "used": [173], "clinic": [176], "for": [177], "therapeutics,": [182], "describing": [183], "properties,": [185], "discussing": [186], "technical": [187], "advancements": [188], "led": [190], "approval,": [193], "highlighting": [195], "examples": [196], "drugs": [200], "make": [202], "use": [203], "technologies.": [206]}